Theralink Technologies, Inc.
THER
$0.00
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -19.05M | 9.62M | 4.50M | -8.57M | -36.46M |
| Total Depreciation and Amortization | 46.30K | 51.40K | 52.20K | 54.20K | 50.50K |
| Total Amortization of Deferred Charges | 3.02M | 4.63M | 4.60M | 4.45M | 1.60M |
| Total Other Non-Cash Items | 14.02M | -17.27M | -10.90M | 2.08M | 32.65M |
| Change in Net Operating Assets | 998.40K | 1.48M | 996.80K | 237.50K | 374.70K |
| Cash from Operations | -962.80K | -1.50M | -752.80K | -1.74M | -1.78M |
| Capital Expenditure | -- | -155.40K | 0.00 | 0.00 | -8.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -155.40K | 0.00 | 0.00 | -8.00K |
| Total Debt Issued | -- | 2.90M | 583.70K | 831.90K | 2.65M |
| Total Debt Repaid | -10.90K | -263.10K | -13.70K | -13.30K | -132.90K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -10.90K | 2.63M | 570.00K | 818.60K | 2.52M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -973.70K | 972.40K | -182.80K | -923.00K | 737.40K |